Stockreport

Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion [Yahoo! Finance Canada]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF The company, which has a strong foothold in HIV drugs and liver disease treatments, has ?been looking for growth beyond its core areas as it faces declining sales of it [Read more]